News
RDHL
0.4278
-3.32%
-0.0147
RedHill Biopharma Advances COVID-19 Antiviral Study
TipRanks · 8h ago
REDHILL ANNOUNCES FIRST PATIENT ENROLLED IN U.S. GOVERNMENT-SUPPORTED COVID-19 STUDY
Reuters · 9h ago
Weekly Report: what happened at RDHL last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at RDHL last week (0408-0412)?
Weekly Report · 04/15 10:26
RedHill GAAP EPS of $0.01, revenue of $6.53M
Seeking Alpha · 04/08 18:07
RedHill Biopharma’s Strategic Pivot and Financial Turnaround
TipRanks · 04/08 14:27
REDHILL BIOPHARMA LTD: STRATEGIC BUSINESS TRANSACTIONS INCLUDE POTENTIAL DIVESTMENT OF CERTAIN OF OUR ASSETS AND/OR COMMERCIAL OPERATIONS
Reuters · 04/08 13:23
Weekly Report: what happened at RDHL last week (0401-0405)?
Weekly Report · 04/08 10:29
RedHill Biopharma Secures $1.25M in Direct Offering
TipRanks · 04/04 20:57
RedHill Biopharma Announces Securities Sale
TipRanks · 04/03 12:00
RedHill Biopharma’s Premium Direct Offering
TipRanks · 04/02 11:57
RedHill Biopharma looks to raise $1.25M in a direct offering of securities
RedHill Biopharma looks to raise $1.25M in a direct offering of securities. The stock price dropped 8.5% on Tuesday during pre-market hours of trading. The company intends to use the net proceeds from the offering for general corporate purposes.
Seeking Alpha · 04/02 11:32
BRIEF-Redhill Biopharma Announces $1.25 Mln Registered Direct Offering At A Premium To Market Price
Reuters · 04/02 11:13
Weekly Report: what happened at RDHL last week (0325-0329)?
Weekly Report · 04/01 10:28
Weekly Report: what happened at RDHL last week (0318-0322)?
Weekly Report · 03/25 10:31
RedHill Biopharma Share Capital Increase Approved
TipRanks · 03/21 20:57
RedHill Biopharma Reschedules Shareholders Meeting
TipRanks · 03/20 21:58
Weekly Report: what happened at RDHL last week (0311-0315)?
Weekly Report · 03/18 10:29
BRIEF-Redhill Biopharma Got Letter From Nasdaq Indicating Bid Price For ADSS Had Closed Below Minimum Requirement For Continued Listing On March 11
Redhill Biopharma Got Letter From Nasdaq Indicating Bid Price For ADSS Had Closed Below Minimum Requirement For Continued Listing On March 11. Company says it got letter from Nasdaq saying bid price for ADSS had closed below minimum requirement for continued listing.
Reuters · 03/14 21:27
Weekly Report: what happened at RDHL last week (0304-0308)?
Weekly Report · 03/11 10:27
More
Webull provides a variety of real-time RDHL stock news. You can receive the latest news about Redhill Biopharm through multiple platforms. This information may help you make smarter investment decisions.
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.